Article Details

Disc Medicine Expands Hematology Pipeline with Worldwide Licensing Agreement for Bitopertin, a ...

Retrieved on: 2021-05-27 20:26:15

Tags for this article:

Click the tags to see associated articles and topics

Disc Medicine Expands Hematology Pipeline with Worldwide Licensing Agreement for Bitopertin, a .... View article details on hiswai:

Excerpt

Hoffmann-La Roche Ltd for the development and commercialization of bitopertin, an orally administered GlyT1 inhibitor with demonstrated effects on the ...

Article found on: www.prnewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up